Hypha are pleased to announce the launch of their One-Stop Metabolite Production Service, strengthening Hypha’s reputation as a go-to company… read more →
Hypha’s PolyCYPs enzymes have been routinely used by pharma and agchem companies for producing metabolites. One application involves direct comparison… read more →
Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st… read more →
Our newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on… read more →
Hypha are excited to present a poster describing the application of PolyCYPs enzyme kits to create oxidised derivatives of drug… read more →
We have just published an article on “Accessing Difficult-to-Synthesise Metabolites in Drug Development Programmes” in the April 2019 edition of… read more →
A paper has just been published, with Hypha as co-authors, on an international collaboration to discover new drugs to treat… read more →
Following the success of Hypha’s live webinars on our PolyCYPs platform, there is an opportunity to hear the webinar on… read more →
22nd January, 2019 Hypha are pleased to announce the official launch of their PolyCYPs® kit, which provide a fast and… read more →
Hypha are delighted to announce the appointment of Lisbet Kvaerno PhD as Head of Synthetic Chemistry at Hypha. Lisbet has… read more →